Radioiodine

Editorial Radioiodine: 80 years and counting; the past, present, and future by Matthew D Ringel Thematic Review Radioiodine treatment: an historical and future perspective by Patricia Borges de Souza and Christopher John McCabe Tailoring the approach to radioactive iodine treatment in thyroid cancer by Sarah E Mayson, Christine M Chan, and Bryan R Haugen The complex regulation of NIS expression and activity in thyroid and extrathyroidal tissues by Garcilaso Riesco-Eizaguirre, Pilar Santisteban, and Antonio De la Vieja Na+/I− symporter expression, function, and regulation in non-thyroidal tissues and impact on thyroid cancer therapy by Sissy M Jhiang and Jennifer A Sipos Redifferentiation-facilitated radioiodine therapy in thyroid cancer by Livia Lamartina et al. The sodium iodide symporter (NIS): novel applications for radionuclide imaging and treatment by C Spitzweg et al. Research Development of improved SRC-3 inhibitors as breast cancer therapeutic agents by Li Qin et al. Targeted genomic analysis of 364 adrenocortical carcinomas by Nikita Pozdeyev et al. Antitumor immune response is associated with favorable survival in GEP-NEN G3 by Vivian Rosery et al.

Access the issue online